Nightmares and terminal insomnia in depressed patients with and without melancholic features

Lutfullah Besiroglu1, Mehmet Yucel Agargun, Rifat Inci

  • 1Department of Psychiatry, School of Medicine, Yuzuncu Yil University, Van 65200, Turkey. lbesiroglu@yyu.edu.tr

Psychiatry Research
|March 3, 2005
PubMed

Insights

Nightmares are more common in people with depression and melancholic features (MF). This suggests that morning depressed mood might be linked to negative dream experiences in depression.

Area of Science:

  • Psychiatry
  • Sleep Medicine
  • Clinical Psychology

Background:

  • Melancholic features (MF) are a specifier for major depressive disorder.
  • Nightmares are recurrent disturbing dreams that can significantly impact mental health.
  • The relationship between MF and nightmare prevalence in depression requires further investigation.

Purpose of the Study:

  • To examine the association between melancholic features and the occurrence of nightmares in patients diagnosed with depression.
  • To compare nightmare frequency in depressed individuals with and without melancholic features.

Main Methods:

  • A comparative study design was employed.
  • Two groups of depressed patients were assessed: those with MF (n=82) and those without MF (n=75).
  • The presence and frequency of nightmares were evaluated in both groups.

Main Results:

  • Nightmares were found to be significantly more frequent in the depressed patients exhibiting melancholic features compared to those without.
  • A higher prevalence of nightmares was observed in the MF group.

Conclusions:

  • Melancholic features in depression are associated with an increased likelihood of experiencing nightmares.
  • The findings suggest a potential link between morning depressed mood and negative dream content in the context of depression.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...